ClinicalTrials.gov
public full text
Public Domain
Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion
This clinical trial investigates contrast-enhanced mammography (CEM) in detecting breast cancer. CEM is similar to standard mammography, but it includes an injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. Diagnostic procedures, such as CEM, may increase the chance of finding breast cancers and decrease the risk of having unnecessary biopsies.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?#1126441
- Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast Findings#1030387
- Sustainability of contrast-enhanced breast imaging: a review of current evidence.#284977
- Sustainability of contrast-enhanced breast imaging: a review of current evidence#279400
- Energy consumption of standard and contrast-enhanced mammography: a step towards sustainable breast imaging#311565
Record · ID 1262772
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive